NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment

OBJECTIVE: 3-iodothyronamine (T(1)AM), an analog of thyroid hormone, is a recently discovered fast-acting endogenous metabolite. High single dose treatments of T(1)AM have produced rapid short-term effects, including a reduction of body temperature, bradycardia, and hyperglycemia in mice. DESIGN AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Haviland, J. A., Reiland, H., Butz, D. E., Tonelli, M., Porter, W. P., Zucchi, R., Scanlan, T. S., Chiellini, G., Assadi-Porter, F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692609/
https://www.ncbi.nlm.nih.gov/pubmed/23512955
http://dx.doi.org/10.1002/oby.20391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692609/
https://www.ncbi.nlm.nih.gov/pubmed/23512955
http://dx.doi.org/10.1002/oby.20391

Ejemplares similares